Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GT Biopharma (GTBP) Other Non-Current Liabilities (2016)

GT Biopharma (GTBP) has disclosed Other Non-Current Liabilities for 2 consecutive years, with $184000.0 as the latest value for Q3 2016.

  • On a quarterly basis, Other Non-Current Liabilities changed N/A to $184000.0 in Q3 2016 year-over-year; TTM through Sep 2016 was $184000.0, a N/A change, with the full-year FY2015 number at $33.3 million, changed N/A from a year prior.
  • Other Non-Current Liabilities was $184000.0 for Q3 2016 at GT Biopharma, down from $33.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $33.3 million in Q4 2015 to a low of $184000.0 in Q3 2016.